Diffuse midline glioma, H3K27-altered: illuminating the dark side of the moon

- Dun, Matthew D., Odia, Yazmin, Arrillaga-Romany, Isabel

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Kearney, Padraic S., Jamaluddin, M. Fairuz B., Douglas, Alicia M., Beitaki, Tyrone, McEwen, Holly P., Persson, Mika L., Hocke, Emily A., Jain, Vaibhav, Aksu, Michael, Manning, Elizabeth E., Parackal, Sarah G., Murray, Heather C., Verrills, Nicole M., Hua, Susan, Cairns, Murray J., Alvaro, Frank, Dayas, Christopher V., Dun, Matthew D., Hua, S, de Bock, CE, Colino-Sanguino, Y, Kiltschewskij, Dylan, Valdes-Mora, F, Tsoli, M, Ziegler, DS, Cairns, MJ, Raabe, EH, Vitanza, NA, Hulleman, E, Phoenix, TN, Koschmann, C, Alvaro, F, Findlay, Izac J., Dayas, CV, Tinkle, CL, Wheeler, H, Whittle, JR, Eisenstat, DD, Firestein, R, Mueller, S, Valvi, S, Hansford, JR, Ashley, DM, Mannan, Abdul, Gregory, SG, Kilburn, LB, Nazarian, J, Cain, JE, Dun, MD, Staudt, Dilana E., Thomas, Bryce C., Germon, Zacary P., Laternser, Sandra

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.

- Noll, Alyssa, Myers, Carrie, Winter, Conrad, Pakiam, Fiona, Leary, Sarah E. S., Cole, Bonnie L., Jackson, Evangeline R., Dun, Matthew D., Foster, Jessica B., Evans, Myron K., Pattwell, Siobhan S., Olson, James M., Biery, Matthew C., Vitanza, Nicholas A., Meechan, Michael, Tahiri, Sophie, Rajendran, Asmitha, Berens, Michael E., Paine, Danyelle, Byron, Sara, Zhang, Jiaming

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies

- Persson, Mika L., Douglas, Alicia M., Alvaro, Frank, Faridi, Pouya, Larsen, Martin R., Alonso, Marta M., Vitanza, Nicholas A., Dun, Matthew D.

Signal transduction in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Alvaro, Frank, Nixon, Brett, Hondermarck, Hubert, Dun, Matthew D.